Biotechnology News

July 31, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. (NASDAQ:HPTX) announced today the completion of its initial public offering of 5,000,000 shares of common stock. In addition, the underwriters of its initial public...

July 31, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (NASDAQ: TRNS) (“Transcat” or the “Company”), a leading distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair,...

July 31, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Q2 Earnings Release

July 31, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (NVDL.PK) reports unaudited financial results for the six months ended June 30, 2012.

July 31, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) today announced that patient enrollment has begun in the first Phase 3 clinical trial of BromSite™ (ISV-303) for the reduction of pain and inflammation after cataract...

July 31, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter ended June 30, 2012. Total revenues for the second quarter of 2012 were $1.8 million, a decrease of $1.3 million from the...

July 31, 2012

BOULDER, Colo.--(BUSINESS WIRE)--ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe pain.

July 31, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2012. Total revenue for the quarter was $66.4 million, including approximately $1.4 million in revenue from...

July 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the second quarter ending June 30, 2012 on Monday, August 6, 2012,...

July 31, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--MedtechWomen today announced that registration is now open for MedtechVision 2012: The Empowered Patient, the second annual conference designed by and for women on the forefront of medical innovation. The...

July 31, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Intermountain Healthcare today announced a joint effort with GE Healthcare to help further reduce radiation dose in Computed Tomography (CT) procedures at its facilities by up to 50 percent*.

July 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Prosetta Antiviral Inc today announced the execution of a strategic alliance with Bristol-Myers Squibb Company (NYSE: BMY) to further discover and develop select drug candidates representing new, novel classes of...

July 31, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is excited to announce the finalization of a deal with German botanical...

July 31, 2012

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Tymora Analytical Operations has started to generate revenue from its PolyMAC drug development technology thanks to funding from National Science Foundation and Purdue's Emerging Innovations Fund.

July 31, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD Earns Highest Ratings for Customer Loyalty and Overall Value Among Phase I Providers in ISR Report

July 31, 2012

CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--BioPharm America™, to be held September 19–21, 2012 in Boston, MA has an unprecedented program line-up featuring top CEOs for what will be the most influential US life science partnering event of...

July 31, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--The headline and first graph of the release should read Wednesday, August 8th (sted: Thursday, August 8th). The corrected release reads: ADVANCED CELL TECHNOLOGY TO ANNOUNCE SECOND QUARTER FINANCIAL RESULTS ON...

July 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anchor Therapeutics has entered into a research collaboration with Kyowa Hakko Kirin for Anchor's pepducin technology.

July 31, 2012

NEW YORK--(BUSINESS WIRE)--The International AIDS Vaccine Initiative (IAVI) today announced the appointment to its Board of Directors of Alice P. Albright and Dr. Purnima Mane.

July 31, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics to Extend Warrant Expiry date

July 31, 2012

BOSTON--(BUSINESS WIRE)--Highland Instruments, Inc., Announces Award of Small Business Innovation Research (“SBIR”) Grant for Clinical Evaluation of Non-Invasive Brain Stimulation Technologies.

July 31, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech is hosting a three-part series of free, educational webinars spanning several weeks in August 2012. This webinar series is ideal for healthcare, medical device organizations and physician practice...

July 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced that FG-3019, the Company’s human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug...

July 31, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife’s subsidiary in the U.S.A., Vitrolife, Inc, has together with Southwest Transplant Alliance and University of Texas been sued for compensation by relatives to a patient who deceased...

July 31, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Labcyte has announced that The Institute of Cancer Research (ICR) has implemented its Access™ Laboratory Workstation to automate the production of low-volume, assay-ready microplates.

July 31, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics and Advanced Liquid Logic Finalize Technology and Collaboration Agreements to Develop an All-Digital Fully Integrated Diagnostic Platform

July 31, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it will report financial results for the second quarter of 2012 on...

July 31, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the quarter ended June 30, 2012, on Thursday, August 9, 2012 at approximately 4:00 p.m. ET / 1:00 p.m. PT. The announcement will be...

July 31, 2012

SAN ANTONIO--(BUSINESS WIRE)--GenSpera approved by FDA to initiate G-202 PhaseII trial in prostate cancer.

July 31, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc., a specialty pharmaceutical company, today announced the appointment of Robert Rosen to its board of directors.

July 31, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that it will host a teleconference and webcast with management to provide a general business overview, as well as to discuss its second quarter 2012 financial...

July 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Fibrosis Platform and Pipeline Attracting Broad Interest from Pharmaceutical and Mid-to-Large Biotech Organizations

July 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--CytomX Therapeutics Expands Series B Financing; Canaan Partners Joins Syndicate

July 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 7, 2012, at 8:30 a.m. ET. During the call, management will provide an update on Infinity's business and discuss the...

July 31, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research has relocated its headquarters 1.5 miles from the original site in King of Prussia, Pa., where the company has been located for the past ten years.

July 31, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE):   ($ in millions, except per share amounts)     Second-Quarter     Year-to-Date 2012     2011(4)     Change 2012     2011(4)     Change Reported Revenues $ 15,057 $ 16,485 (9%) $ 29,942 $ 32,509...

July 31, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today reported second quarter 2012 financial results. Adjusted net income increased $28.4 million to $41.0 million in the second quarter 2012, or $0.60 per diluted share,...

July 31, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, a leading provider of orthopedic and other biologic implants, reported operating results for the second quarter of 2012.

July 31, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Reports Second Quarter 2012 Results

July 31, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/htww9f...

July 31, 2012

LINKÖPING, Sweden--(BUSINESS WIRE)--Regulatory News: As at July 31, 2012, the number of shares in Sectra AB (STO:SECTB) amounts to 74,189,956, of which 5,241,384 are Series A and 68,948,572 are Series B. This entails an increase of 37,094,987 in...

July 30, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Announces European Market Clearance for its Innovative Vascular Access Catheter

July 30, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Pharmaceuticals Announces Closing of Priligy® Asset Transfer and License Agreements

July 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the submission of a New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA)....

July 30, 2012

SEATTLE--(BUSINESS WIRE)--July 30, 2012--Dendreon Corporation (NASDAQ:DNDN) today reported results for the quarter ended June 30, 2012. Net product revenue for the quarter was $80.0 million compared to $48.1 million for the quarter ended June 30...

July 30, 2012

SEATTLE--(BUSINESS WIRE)--July 30, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced a strategic restructuring plan designed to accelerate the Company’s path to profitability and future growth. The plan includes re-configuring Dendreon’s...

July 30, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its second quarter 2012 financial results on Wednesday, August 8, 2012, before the open of the U.S. financial markets. Clovis’ senior management will host a...